Results of phase I trial of novel herbal therapy for men at high risk of prostate cancer
Friday, May 22, 2009 - 16:49
in Health & Medicine
Results of a phase I clinical trial of a novel herb-based therapeutic called Zyflamend have demonstrated that the therapy is associated with minimal toxicity and no serious adverse events in men at high-risk for developing prostate cancer.